{"id":"https://openalex.org/W2117337658","doi":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","title":"Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments","display_name":"Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments","alternate_titles":[],"publication_year":2003,"publication_date":"2003-10-24","ids":{"openalex":"https://openalex.org/W2117337658","doi":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","mag":"2117337658","pmid":"https://pubmed.ncbi.nlm.nih.gov/14576092","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/253807"},"language":"en","primary_location":{"id":"doi:10.1128/aac.47.11.3384-3392.2003","doi":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2117337658"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC253807","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016472667","display_name":"Reine Note","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Reine Note","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091165095","display_name":"Caroline Maisonneuve","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Maisonneuve","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109251124","display_name":"Philippe Lett\u00e9ron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Lette\u0301ron","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061527531","display_name":"Gilles Peytavin","orcid":"https://orcid.org/0000-0002-4359-537X","observed_orcids":["https://orcid.org/0000-0002-4359-537X"]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Peytavin","raw_affiliation_strings":["Pharmacie, Ho\u0302pital Bichat"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie, Ho\u0302pital Bichat","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018666707","display_name":"Fatima Djouadi","orcid":"https://orcid.org/0000-0003-0350-0935","observed_orcids":["https://orcid.org/0000-0003-0350-0935"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fatima Djouadi","raw_affiliation_strings":["INSERM Unite\u0301 393, Ho\u0302pital Necker-Enfants Malades"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 393, Ho\u0302pital Necker-Enfants Malades","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035818196","display_name":"Anissa Igoudjil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anissa Igoudjil","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111498081","display_name":"Marie-Christine Guimont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799502834","display_name":"H\u00f4pital Beaujon","ror":"https://ror.org/03jyzk483","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2799502834","https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Christine Guimont","raw_affiliation_strings":["AP-HP, Service de Biochimie, Ho\u0302pital Beaujon, Clichy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP, Service de Biochimie, Ho\u0302pital Beaujon, Clichy","institution_ids":["https://openalex.org/I2799502834","https://openalex.org/I4210097159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012050300","display_name":"M Biour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Biour","raw_affiliation_strings":["Unite\u0301 de Pharmacovigilance, Ho\u0302pital Saint Antoine, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite\u0301 de Pharmacovigilance, Ho\u0302pital Saint Antoine, Paris, France","institution_ids":["https://openalex.org/I4210102928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021514439","display_name":"Dominique Pessayre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dominique Pessayre","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021292416","display_name":"Bernard Fromenty","orcid":"https://orcid.org/0000-0003-2994-5465","observed_orcids":["https://orcid.org/0000-0003-2994-5465"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bernard Fromenty","raw_affiliation_strings":["INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unite\u0301 481 and Centre Claude Bernard de Recherches sur les He\u0301patites Virales","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9355,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.86098866,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"47","issue":"11","first_page":"3384","last_page":"3392"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.6333000063896179,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.6333000063896179,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.357699990272522,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10301","display_name":"Mitochondrial Function and Pathology","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":1.0},{"id":"https://openalex.org/keywords/didanosine","display_name":"didanosine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.996999979019165},{"id":"https://openalex.org/keywords/zalcitabine","display_name":"zalcitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mitochondrial-dna","display_name":"mitochondrial DNA","score":0.8859999775886536},{"id":"https://openalex.org/keywords/plasma-ketone-bodies","display_name":"plasma ketone bodies","score":0.7689999938011169},{"id":"https://openalex.org/keywords/beta-aminoisobutyric-acid","display_name":"beta-aminoisobutyric acid","score":0.8730000257492065},{"id":"https://openalex.org/keywords/fatty-acid-beta-oxidation","display_name":"fatty acid beta-oxidation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/fat-metabolism","display_name":"fat metabolism","score":0.5450000166893005},{"id":"https://openalex.org/keywords/blood-lactate","display_name":"blood lactate","score":0.6690000295639038},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.876980721950531},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.684836745262146},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5606036186218262},{"id":"https://openalex.org/C2777447569","wikidata":"https://www.wikidata.org/wiki/Q422606","display_name":"Didanosine","level":5,"score":0.5055460929870605},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.47556084394454956},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42166972160339355},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.40859705209732056},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3530244827270508},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3425825238227844},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3410113453865051},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.24462217092514038},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.15951025485992432},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.15910494327545166},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.14362958073616028},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13764292001724243},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000621","descriptor_name":"Aminoisobutyric Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007657","descriptor_name":"Ketone Bodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008660","descriptor_name":"Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015152","descriptor_name":"Blotting, Northern","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019289","descriptor_name":"Pyruvic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019344","descriptor_name":"Lactic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1128/aac.47.11.3384-3392.2003","doi":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.47.11.3384-3392.2003","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:119527","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC253807","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:14576092","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14576092","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:253807","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC253807/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.335.8489","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.335.8489","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/47/11/3384.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:119527","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC253807","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W50786709","https://openalex.org/W161797012","https://openalex.org/W1551770211","https://openalex.org/W1839197698","https://openalex.org/W1851873892","https://openalex.org/W1941726919","https://openalex.org/W1949188500","https://openalex.org/W1966800194","https://openalex.org/W1978724449","https://openalex.org/W1978902758","https://openalex.org/W1983317287","https://openalex.org/W1988065964","https://openalex.org/W1990091214","https://openalex.org/W1997788389","https://openalex.org/W1998660799","https://openalex.org/W2008681391","https://openalex.org/W2010520981","https://openalex.org/W2016716965","https://openalex.org/W2018687008","https://openalex.org/W2021463753","https://openalex.org/W2030580922","https://openalex.org/W2041841997","https://openalex.org/W2046073414","https://openalex.org/W2046244841","https://openalex.org/W2051709370","https://openalex.org/W2057404134","https://openalex.org/W2059032719","https://openalex.org/W2068078604","https://openalex.org/W2068700579","https://openalex.org/W2073056291","https://openalex.org/W2084905499","https://openalex.org/W2085653450","https://openalex.org/W2092297057","https://openalex.org/W2092585475","https://openalex.org/W2103116278","https://openalex.org/W2110484800","https://openalex.org/W2110572140","https://openalex.org/W2113892466","https://openalex.org/W2126327126","https://openalex.org/W2126553984","https://openalex.org/W2133315239","https://openalex.org/W2134270245","https://openalex.org/W2134812217","https://openalex.org/W2144444103","https://openalex.org/W2146071510","https://openalex.org/W2148825772","https://openalex.org/W2154179429","https://openalex.org/W2164676747","https://openalex.org/W2171662092","https://openalex.org/W2178164598","https://openalex.org/W2253542416","https://openalex.org/W2321741507","https://openalex.org/W2442872057","https://openalex.org/W3151623739","https://openalex.org/W4243072854"],"related_works":["https://openalex.org/W2041123641","https://openalex.org/W2041043870","https://openalex.org/W2133946149","https://openalex.org/W2017359142","https://openalex.org/W2000184925","https://openalex.org/W2033035424","https://openalex.org/W2171046929","https://openalex.org/W2141163306","https://openalex.org/W2039515318","https://openalex.org/W2397628039"],"abstract_inverted_index":{"Although":[0],"treatments":[1],"with":[2,61,86,144,156,180,187],"nucleoside":[3],"reverse":[4],"transcriptase":[5],"inhibitors":[6],"(NRTIs)":[7],"can":[8],"modify":[9],"fat":[10,13],"metabolism":[11],"and":[12,22,34,48,53,75,201,224,234,249,252],"distribution":[14],"in":[15,55,77,99,111,177,230],"humans,":[16],"the":[17,23,32,66,91,115,137,145,163,170,202,240],"mechanisms":[18],"of":[19,25,37,73,117,139,147,152,172,205,214,237,242],"these":[20,82,253],"modifications":[21],"roles":[24],"diverse":[26],"NRTIs":[27,129,215],"are":[28,256],"unknown.":[29],"We":[30],"studied":[31],"mitochondrial":[33,93,203,222,245],"metabolic":[35],"effects":[36,220,226,255],"stavudine":[38],"(d4T),":[39],"zidovudine":[40],"(AZT),":[41],"didanosine":[42],"(ddI),":[43],"lamivudine":[44],"(3TC),":[45],"zalcitabine":[46],"(ddC),":[47],"three":[49],"combinations":[50],"(AZT-3TC,":[51],"d4T-3TC,":[52],"d4T-ddI)":[54],"mice":[56,178],"treated":[57,179],"for":[58],"2":[59],"weeks":[60],"daily":[62],"doses":[63,151,213,236],"equivalent":[64],"to":[65],"human":[67],"dose":[68],"per":[69],"body":[70],"area.":[71],"Concentrations":[72],"AZT":[74,148,233],"d4T":[76,121,153,238],"plasma":[78,140,173,228],"were":[79,84,130],"lower":[80],"when":[81,128],"drugs":[83],"administered":[85,131],"3TC":[87],"or":[88,103,120,149,159,190,218],"ddI.":[89],"Whatever":[90],"treatment,":[92],"DNA":[94,223],"was":[95,108,125],"not":[96,155],"significantly":[97],"decreased":[98,110],"muscle,":[100],"heart,":[101],"brain,":[102],"white":[104],"adipose":[105],"tissue":[106,113],"but":[107,154],"moderately":[109],"liver":[112],"after":[114],"administration":[116,146],"AZT,":[118,188],"3TC,":[119,158],"alone.":[122],"Blood":[123],"lactate":[124,229],"unchanged,":[126],"even":[127],"at":[132],"supratherapeutic":[133],"doses.":[134],"In":[135,210],"contrast,":[136],"level":[138],"ketone":[141,174,206,250],"bodies":[142,175,207],"increased":[143,176,193],"high":[150,235],"ddC,":[157],"ddI,":[160],"suggesting":[161],"that":[162],"thymine":[164,184,262],"moiety":[165],"could":[166],"be":[167],"involved.":[168],"Indeed,":[169],"levels":[171,241],"beta-aminoisobutyric":[181,191,259],"acid,":[182,260],"a":[183,261],"catabolite.":[185],"Treatment":[186],"d4T,":[189],"acid":[192,247],"hepatic":[194,243],"carnitine":[195],"palmitoyltransferase":[196],"I":[197],"(CPT-I)":[198],"mRNA":[199],"expression":[200],"generation":[204],"from":[208],"palmitate.":[209],"conclusion,":[211],"therapeutic":[212],"have":[216],"no":[217,225],"moderate":[219],"on":[221,227],"mice.":[231],"However,":[232],"increase":[239],"CPT-I,":[244],"fatty":[246],"beta-oxidation,":[248],"bodies,":[251],"catabolic":[254],"reproduced":[257],"by":[258],"metabolite.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2117337658","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
